Rapid progressive Alzheimer’s disease (rpAD): clinical and molecular characterization of a distinct subtype of AD

Rapid progressive Alzheimer’s disease (rpAD): clinical and molecular characterization of a distinct subtype of AD

www.alzheimer.med.uni-goettingen.de
[email protected]

Germany

Neuropsychological test, neurological exam, MRI, CSF, follow up tests

Alzheimer’s disease and other dementias

Data to be made publicly available immediately

Yes

Yes, for all the cohort

Yes

No

Data collection ongoing|Data analysis ongoing
01/01/2009

No
Progression rate
Yes

0-500 clinical cases
0

To determine factors for disease progression
Rapid progressive Alzheimer’s disease (rpAD): clinical and molecular characterization of a distinct subtype of AD

Disease Registers
Germany
Alzheimer’s disease & other dementias
2016